Market Closed

AQST
Aquestive Therapeutics
$ 3.91
9.52%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Aquestive Therapeutics News

Latest Aquestive Therapeutics Stock News & AQST Headlines

Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
11 days ago | globenewswire.com
Traders Purchase Large Volume of Put Options on Aquestive Therapeutics (NASDAQ:AQST)
11 days ago | defenseworld.net
Aquestive Therapeutics, Inc. (AQST) Q3 2026 Earnings Call Transcript
11 days ago | seekingalpha.com
What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
11 days ago | marketbeat.com
Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates
12 days ago | zacks.com
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
12 days ago | globenewswire.com
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET
20 days ago | globenewswire.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CEO Sells $105,500.00 in Stock
a month ago | defenseworld.net
Aquestive: FDA Acceptance Of Anaphylm Resubmission Makes For Rating Upgrade
a month ago | seekingalpha.com
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027
a month ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

AQST
Aquestive Therapeutics
$ 3.91
9.52%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago